- Home >
- Sitemap
-
Home
- Overview
- About Us
-
Research and Development
- Development and Validation of NIPD Trisomy 21 Test
- Publications
- Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications
- Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21
- MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21
- Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies
- Sites of differential DNA methylation between placenta and peripheral blood: Molecular markers for noninvasive prenatal diagnosis of aneuploidies
- Non-invasive prenatal diagnosis: An epigenetic approach to the detection of common fetal chromosome disorders by analysis of maternal blood samples
- Intellectual Property
-
News
- Press Releases
- Spotlight News
- Scientists develop blood test for Down's syndrome
- Simple blood test for Down's syndrome is on its way, say scientists
- Noninvasive test may identify Down syndrome early on
- Blood test developed to check for Down's syndrome in pregnant womens' children
- Mother's blood test may find Down syndrome
- Genetics: Prenatal test for Down's syndrome
- Cypriot group develops non-invasive, prenatal Down syndrome dx; creates startup to market test
- Noninvasive prenatal tests for Down syndrome are near
- NIPD Genetics Raises €2.5M to Fund Development of Noninvasive Down Syndrome Dx
- A new era of non-invasive prenatal genetic diagnosis: exploiting fetal epigenetic differences
- Cyprus' NIPD Genetics Validates Updated Trisomy 21 Assay; Eyes 2013 Launch for Testing Services
- NIPD Genetics receives SME of 2012 Award from IN Business
- Terms of Use
- Privacy Policy
- Contact Us